Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | POLA1 | P09884 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31049868 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1L3MBTL1KMT2A | |
| SCHEMBL4006166 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1L3MBTL1KMT2A | |
| SCHEMBL1365242 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1L3MBTL1KMT2A | |
| SCHEMBL11849992 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1L3MBTL1KMT2A | |
| SCHEMBL16719251 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1L3MBTL1KMT2A | |
| SCHEMBL1115015 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1L3MBTL1KMT2A | |
| SCHEMBL8973175 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1L3MBTL1KMT2A | |
| SCHEMBL1365853 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1L3MBTL1KMT2A | |
| SCHEMBL1285241 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1L3MBTL1KMT2A | |
| SCHEMBL31734806 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1L3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110724052-B | Eugenol surfactant and application thereof | 江南大学 | 2020-12-29 | — | — | CN | claimed |
| CN-110724052-A | Eugenol surfactant and application thereof | 江南大学 | 2020-01-24 | — | — | CN | claimed |
| EP-3532528-A1 | RENEWABLY DERIVED POLYAMIDES AND METHODS OF MAKING THE SAME | Elevance Renewable Sciences, Inc. (US) | 2019-09-04 | — | — | EP | claimed |
| CN-109843976-A | The polyamide and its manufacturing method obtained by renewable source | 埃莱万斯可再生能源科学股份有限公司 | 2019-06-04 | — | — | CN | claimed |
| WO-2018080869-A1 | RENEWABLY DERIVED POLYAMIDES AND METHODS OF MAKING THE SAME | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2018-05-03 | — | — | WO | claimed |
| CN-102350278-B | Preparation of drug-carrying chitosan microspheres | UNIV BEIJING CHEMICAL | 2013-06-12 | — | — | CN | claimed |
| CN-102350278-A | Preparation of drug-carrying chitosan microspheres | UNIV BEIJING CHEMICAL | 2012-02-15 | — | — | CN | claimed |
| CN-1580036-A | Method for synthesizing 10-P-nitrobenz-oxy-capric acid | UNIV ZHEJIANG (CN) | 2005-02-16 | — | — | CN | claimed |
| CN-1580032-A | Method for synthesizing 10-bromo methyl caprate | UNIV ZHEJIANG (CN) | 2005-02-16 | — | — | CN | claimed |
| US-5908723-A | Recording sheets | XEROX CORPORATION (US) | 1999-06-01 | — | — | US | claimed |
| CN-122055150-A | Cyproheptadine derivatives | 思凯生科股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20250361250-A1 | FLUORINE-CONTAINING SILANE COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2025-11-27 | — | — | US | disclosed |
| US-20250288683-A1 | TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS | Treeline Biosciences, Inc. | 2025-09-18 | — | — | US | disclosed |
| EP-4608876-A2 | ENDOCYTIC AGENTS | BioVentures, LLC (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-4569012-A1 | EFFICIENT SYNTHESIS OF VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS | University of Utah Research Foundation (US) | 2025-06-18 | — | — | EP | disclosed |
| EP-0190042-B1 | ORGANIC COMPOUNDS AND THEIR PHARMACEUTICAL USE | Lilly Industries Limited (GB) | 1991-10-30 | — | — | EP | disclosed |
| US-4997847-A | Thromboxane A2 antagonists | SMITH KLINE & FRENCH LABORATORIES LIMITED (DE) | 1991-03-05 | — | — | US | disclosed |
| EP-0304271-A2 | Omega-arylsulphonamidoalkanoic acids for treatment of thromboxane medited diseases | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1989-02-22 | — | — | EP | disclosed |
| US-4675335-A | LEUKOTRIENE ANTAGONISTS | LILLY INDUSTRIES LIMITED (GB) | 1987-06-23 | — | — | US | disclosed |
| EP-0190042-A2 | Organic compounds and their pharmaceutical use | Lilly Industries Limited (GB) | 1986-08-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250361250-A1 | FLUORINE-CONTAINING SILANE COMPOUND | FLI1, AFF1, RFT1 | TSHR 2035/4885LMNA 1768/4885ALDH1A1 879/4885 |
| US-20250288683-A1 | TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS | BCL2L1, BCL2, BCL2L10 | TSHR 3777/4885LMNA 3184/4885ALDH1A1 2981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.